HCMT
ALXN
Highland Capital Management (Texas)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-6,950
| Closed | -$774K | – | 369 |
|
|
2018
Q1 | $774K | Buy |
6,950
+1,300
| +23% | +$145K | 0.04% | 186 |
|
|
2017
Q4 | $675K | Sell |
5,650
-16,300
| -74% | -$1.95M | 0.03% | 167 |
|
|
2017
Q3 | $3.08M | Sell |
21,950
-1,900
| -8% | -$267K | 0.14% | 115 |
|
|
2017
Q2 | $2.9M | Hold |
23,850
| – | – | 0.12% | 125 |
|
|
2017
Q1 | $2.89M | Sell |
23,850
-34,450
| -59% | -$4.18M | 0.15% | 111 |
|
|
2016
Q4 | $7.13M | Buy |
58,300
+34,450
| +144% | +$4.21M | 0.33% | 70 |
|
|
2016
Q3 | $2.92M | Sell |
23,850
-34,075
| -59% | -$4.18M | 0.09% | 131 |
|
|
2016
Q2 | $6.76M | Sell |
57,925
-52,364
| -47% | -$6.11M | 0.28% | 81 |
|
|
2016
Q1 | $15.4M | Buy |
+110,289
| New | +$15.4M | 0.68% | 35 |
|
|
2014
Q3 | – | Sell |
-19,768
| Closed | -$3.09M | – | 279 |
|
|
2014
Q2 | $3.09M | Buy |
+19,768
| New | +$3.09M | 0.11% | 117 |
|